Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (181-190 of 350) with videos related to

Pageof 35
Sort By:
Cancer Research|July 15, 1993
Heterogeneity in lineage derivation of Philadelphia-positive acute lymphoblastic leukemia expressing p190BCR-ABL or p210BCR-ABL: determination by analysis of individual colonies with the polymerase chain reactionZ Estrov, M Talpaz, H M Kantarjian, et al.
Human Gene Therapy|February 1, 1993
Use of two retroviral markers to test relative contribution of marrow and peripheral blood autologous cells to recovery after preparative therapy. The University of Texas M.D. Anderson Cancer Center. Division of MedicineA B Deisseroth, H Kantarjian, M Talpaz, et al.
Seminars in Hematology|July 1, 1990
Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defenseJ Gutterman, S Vadhan-Raj, C Logothetis, et al.
Blood|November 1, 1994
Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlatesM Wetzler, R Kurzrock, Z Estrov, et al.
Cancer|February 15, 1991
Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignanciesG Baiocchi, J J Kavanagh, M Talpaz, et al.
Leukemia & Lymphoma|October 8, 1999
Cutaneous ulcers associated with hydroxyurea therapy in myeloproliferative disordersF Ravandi-Kashani, J Cortes, P Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Determinants of prognosis in late chronic-phase chronic myelogenous leukemiaJ Rodriguez, J Cortes, T Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Significance of cytogenetic clonal evolution in chronic myelogenous leukemiaA Majlis, T L Smith, M Talpaz, et al.
Leukemia|March 1, 1991
Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progressionK Dhingra, M Talpaz, H Kantarjian, et al.
The Journal of Clinical Investigation|October 1, 1993
Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiationM Wetzler, M Talpaz, R A Van Etten, et al.
Pageof 35

Showing results (181-190 of 350) with videos related to

Sort By:
Pageof 35
Cancer Research|July 15, 1993
Heterogeneity in lineage derivation of Philadelphia-positive acute lymphoblastic leukemia expressing p190BCR-ABL or p210BCR-ABL: determination by analysis of individual colonies with the polymerase chain reactionZ Estrov, M Talpaz, H M Kantarjian, et al.
Human Gene Therapy|February 1, 1993
Use of two retroviral markers to test relative contribution of marrow and peripheral blood autologous cells to recovery after preparative therapy. The University of Texas M.D. Anderson Cancer Center. Division of MedicineA B Deisseroth, H Kantarjian, M Talpaz, et al.
Seminars in Hematology|July 1, 1990
Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defenseJ Gutterman, S Vadhan-Raj, C Logothetis, et al.
Blood|November 1, 1994
Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlatesM Wetzler, R Kurzrock, Z Estrov, et al.
Cancer|February 15, 1991
Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignanciesG Baiocchi, J J Kavanagh, M Talpaz, et al.
Leukemia & Lymphoma|October 8, 1999
Cutaneous ulcers associated with hydroxyurea therapy in myeloproliferative disordersF Ravandi-Kashani, J Cortes, P Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Determinants of prognosis in late chronic-phase chronic myelogenous leukemiaJ Rodriguez, J Cortes, T Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Significance of cytogenetic clonal evolution in chronic myelogenous leukemiaA Majlis, T L Smith, M Talpaz, et al.
Leukemia|March 1, 1991
Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progressionK Dhingra, M Talpaz, H Kantarjian, et al.
The Journal of Clinical Investigation|October 1, 1993
Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiationM Wetzler, M Talpaz, R A Van Etten, et al.
Pageof 35